Skip to content
AnalystLens

Philip Morris International Inc. Quarterly Report for Q3 Ended Sep 30, 2026

Filing Date
Filed October 23, 2026
Period End
September 30, 2026
Security
PM
In the record · 2016–202610-K1110-Q338-K248

PM filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 248 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Sep ’17Sep ’17
  2. Restructuring8-K · Nov ’19Nov ’19
  3. Leadership change8-K · Dec ’21Dec ’21
  4. Material agreement8-K · Dec ’25Dec ’25

Summary

Summary of the 10-Q filed October 23, 2026. Cited figures are marked; the original filing is the authoritative source.

Philip Morris International Inc. (PMI) reported a net revenue of $32.8 billiona for the nine months ended September 30, 2026, an increase of 8.2% compared to the same period in 2025.

This growth was primarily driven by favorable pricing, particularly in international combustible products, and higher volumes in the international smoke-free segment. Despite strong revenue growth, diluted Earnings Per Share (EPS) saw a decrease of 7.0% to $5.48b for the nine-month period, impacted by factors such as fair value adjustments for equity investments, impairment charges related to the RBH equity investment, and a higher effective tax rate.

The company is actively managing its portfolio evolution towards smoke-free products while maintaining a strong performance in its combustible segment. The company also announced a dividend increase and continues to invest in its smoke-free product portfolio and manufacturing capacity, particularly for its ZYN brand in the U.S., which is expected to impact Q4 profitability due to significant investments and packaging changes.

Key Highlights

  1. Net revenues increased by 8.2% year-over-year to $32.8 billion for the nine months ended September 30, 2026, driven by strong pricing and smoke-free volume growth.
  2. Diluted EPS decreased by 7.0% to $5.48 for the nine months ended September 30, 2026, impacted by investment impairments and higher tax rates.
  3. The company's smoke-free product segment showed robust growth, with shipment volume up 6.4% driven by Heated Tobacco Units (HTU) and E-vapor categories.
  4. The U.S. segment experienced strong revenue growth of 22.7% for the quarter, primarily due to ZYN shipments and favorable pricing, although U.S. profitability is expected to be impacted in Q4 by increased investments and packaging changes.
  5. PMI declared an 8.8% increase in its quarterly dividend to $1.60 per common share, with an annualized rate of $6.40.
  6. Significant investments are planned for the fourth quarter of 2026 to support the ZYN brand in the U.S., including expanded consumer communications and a transition to 20-pouch cans, which is expected to result in temporarily lower U.S. profitability.

Frequently Asked Questions

  1. What drove the revenue growth for Philip Morris International in the first nine months of 2026?

    Revenue growth was primarily driven by favorable pricing, particularly in international combustible products, and higher volumes in the international smoke-free segment. Excluding currency and acquisitions/divestitures, net revenues increased by 5.9%.

  2. Why did Diluted EPS decrease despite revenue growth?

    The decrease in Diluted EPS was mainly due to unfavorable fair value adjustments for equity security investments, a non-cash impairment charge related to the RBH equity investment, and a higher effective tax rate. These factors offset the positive impact of higher operating income and lower interest expense.

  3. What is the company's outlook for its smoke-free products, particularly ZYN in the U.S.?

    PMI expects continued growth in smoke-free products, with high single-digit growth projected for smoke-free shipment volumes and adjusted in-market sales. In the U.S., ZYN shipments are growing, but Q4 2026 profitability is expected to be impacted by significant investments in brand support and a transition to 20-pouch cans, which is designed to enhance value but will reduce revenue per pouch.

  4. What is the status of the company's litigation and regulatory matters?

    PMI is involved in various legal proceedings, including tobacco and nicotine-related litigation and regulatory challenges for smoke-free products. While the company believes it has valid defenses, unfavorable outcomes could materially affect financial results. The company is also subject to evolving regulations across different markets, particularly for its smoke-free products.